30
Jun

Cidara Therapeutics has emerged from stealth mode with a crew of experienced biotech execs, a $32 million bankroll from a slate of top-shelf venture investors and a plan to make a difference in developing frontline antifungal drugs.

…read more

Source: Biotech vets sign up to launch Cidara with $32M, new drugs for fungal infections

    

0 No comments